India News | Phase 2,3 Trial Data of India's First MRNA COVID Vaccine Submitted to DCGI

Get latest articles and stories on India at LatestLY. Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. India News | Phase 2,3 Trial Data of India's First MRNA COVID Vaccine Submitted to DCGI.

Related Keywords

Tamil Nadu ,India ,New Delhi ,Delhi ,Shalini Bhardwaj ,Balram Bhargava ,Read Tamil Nadu Court Sentences ,Indian Council Of Medical Research ,Expert Committee ,Member Health Niti Aayog ,Pune Based Gennova Biopharmaceuticals ,Drugs Controller General ,Tamil Nadu Court Sentences ,Year Old Man ,Sexually Assaulting ,Indian Council ,Medical Research ,Worm Moon ,Niti Aayog ,Subject Expert Committee ,Hyderabad Based Biological ,Receptor Binding Domain ,Precaution Dose ,